感染性疾病甲肝、戊肝的免疫学检验效果研究
|
摘要
目的本次研究主要针对感染性疾病甲肝、戊肝的免疫学检验效果展开分析。方法开展本次研究的时间段为2018年1月至2018年7月,研究内容为我院纳入医治的感染性疾病甲肝、戊肝的80例患者的标本,其中有40例患者标本运用肝炎病毒快速检测试剂术为参照组,剩下40例患者标本运用酶联免疫法为研究组。结果研究组的检测准确度显著比参照组高,P<0.05。结论在对甲肝、戊肝进行免疫学检验时运用酶联免疫法具有更高的准确性,值得在临床上感染性疾病甲肝、戊肝检验中推荐广泛应用。
Objective To analyze and study immunological test effect of hepatitis A and E in infectious diseases.Methods Choose 80 cases infectious hepatitis A and E patients from January 2018 to July 2018 as study samples. 40 cases in reference group were treated with hepatitis virus fast detection reagent, and remaining 40 cases in research group with enzyme-linked immunosorbent assay. Results Detection accuracy of research group was significantly higher than reference group,(P<0.05). Conclusion Enzyme-linked immunosorbent assay(ELISA) has higher accuracy in immunological test of hepatitis A and E, which is worthy of promotion widely in clinical test of infectious diseases such as hepatitis A and hepatitis E.
Objective To analyze and study immunological test effect of hepatitis A and E in infectious diseases.Methods Choose 80 cases infectious hepatitis A and E patients from January 2018 to July 2018 as study samples. 40 cases in reference group were treated with hepatitis virus fast detection reagent, and remaining 40 cases in research group with enzyme-linked immunosorbent assay. Results Detection accuracy of research group was significantly higher than reference group,(P<0.05). Conclusion Enzyme-linked immunosorbent assay(ELISA) has higher accuracy in immunological test of hepatitis A and E, which is worthy of promotion widely in clinical test of infectious diseases such as hepatitis A and hepatitis E.
引文
[1]张美华.探讨感染性疾病甲肝、戊肝的免疫学检验效果[J].临床检验杂志(电子版),2018,7(02):248-250.
[2]周茂锋.感染性疾病甲肝乙肝免疫学检验的临床价值[J].临床医药文献电子杂志,2017,4(10):1824-1825.
[3]田建体.感染性疾病甲肝、戊肝的免疫学检验探究[J].中国农村卫生,2017,5(02):45.
[4]刘新.感染性疾病甲肝、戊肝的免疫学检验质量相关探讨[J].中国卫生标准管理,2017,8(01):106-107.
[5]陈凤仙.感染性疾病甲肝、戊肝的免疫学检验[J].世界最新医学信息文摘,2015,15(69):40-41.
[6]安婧,张晓曙,刘建峰,等.国产甲型肝炎疫苗免疫学效果观察评价[J].中国疫苗和免疫,2012,18(04):307-310+315.
[7]朱奕奕.上海市甲型病毒性肝炎免疫策略评价研究[D].复旦大学,2012.
[8]李思成.灭活轮状病毒与灭活甲肝病毒联合疫苗的制备及免疫学效果评价[D].昆明医学院,2011.
[9]秦保生,孙永波,周健.以免疫策略为主控制甲肝发病的效果评价[J].中国公共卫生管理,2009,25(05):506-508.
[10]熊秋霞.甲乙肝联合疫苗中甲肝乙肝抗原相互作用机制的探索研究[D].中国协和医科大学,2008.
[2]周茂锋.感染性疾病甲肝乙肝免疫学检验的临床价值[J].临床医药文献电子杂志,2017,4(10):1824-1825.
[3]田建体.感染性疾病甲肝、戊肝的免疫学检验探究[J].中国农村卫生,2017,5(02):45.
[4]刘新.感染性疾病甲肝、戊肝的免疫学检验质量相关探讨[J].中国卫生标准管理,2017,8(01):106-107.
[5]陈凤仙.感染性疾病甲肝、戊肝的免疫学检验[J].世界最新医学信息文摘,2015,15(69):40-41.
[6]安婧,张晓曙,刘建峰,等.国产甲型肝炎疫苗免疫学效果观察评价[J].中国疫苗和免疫,2012,18(04):307-310+315.
[7]朱奕奕.上海市甲型病毒性肝炎免疫策略评价研究[D].复旦大学,2012.
[8]李思成.灭活轮状病毒与灭活甲肝病毒联合疫苗的制备及免疫学效果评价[D].昆明医学院,2011.
[9]秦保生,孙永波,周健.以免疫策略为主控制甲肝发病的效果评价[J].中国公共卫生管理,2009,25(05):506-508.
[10]熊秋霞.甲乙肝联合疫苗中甲肝乙肝抗原相互作用机制的探索研究[D].中国协和医科大学,2008.